Business Wire

  1. Current Market Dynamics, Future Market Opportunities And Lifecycle Strategies For Drug Delivery Technologies Industry 10/28/2008
    Research and Markets has announced the addition of the "Drug Delivery Technologies - Current Market Dynamics, Future Market Opportunities and Lifecycle Strategies" report to their offering.
  2. BIO-Europe 2008 To Get Biotech Industry Partnerships Started In Challenging Economic Environment 10/27/2008
    In order to seek out new partnering opportunities, the top 20 big pharma companies will be in attendance on November 17-19 in Mannheim/Heidelberg, Germany for BIO-Europe 2008, the world's largest stand-alone partnering conference.
  3. Agilent Technologies, BioTrove To Streamline Drug Discovery Using High-Throughput Mass Spectrometry 10/27/2008
    Agilent Technologies Inc.and BioTrove today announced that they have signed a non-exclusive value-added reseller agreement to enable BioTrove to provide an end-to-end solution for mass spectrometry-based drug discovery.
  4. Bayer HealthCare's New Sterile Fill Facility Receives EMEA, FDA Licenses 10/27/2008
    The European Medicines Agency (EMEA) has granted license approval to Bayer HealthCare LLC (Bayer) for its new sterile filling facility (SFF) on its Berkeley, Calif. campus.
  5. Guide To Successful Pharmabiotech Alliance Strategies: Providing A Comprehensive Analysis Of Driving Synergies, Avoiding Failure And Managing Relationships 10/24/2008
    Research and Markets http://www.researchandmarkets.com/research/3f2fff/successful_pharmab) has announced the addition of the "Successful Pharmabiotech Alliance Strategies: Driving Synergies, Avoiding Failure and Managing Relationships" report to their offering.
  6. HHS Preparing To Open FDA Offices In China, India, Europe, And Latin America This Year 10/24/2008
    The U.S. Department of Health and Human Services will send the first U.S. Food and Drug Administration (FDA) staff to China, India, Europe, and Latin America before the end of 2008, HHS Secretary Mike Leavitt announced today.
  7. Research and Markets: A 2009 Industry Report On The U.S. Pharmaceutical Preparation Manufacturing Market: Analyse 09/10 Estimates, National Statistics And Historical Trends 10/24/2008
    Research and Markets has announced the addition of the "2009 U.S. Pharmaceutical Preparation Manufacturing Industry Report" report to their offering.
  8. Market Insight And R&D Pipeline Analysis For Cancer Therapeutics 10/22/2008
    Research and Markets (http://www.researchandmarkets.com/research/d98eac/cancer_therapeutic) has announced the addition of the "Cancer Therapeutics - Market Insight and R&D Pipeline Analysis" report to their offering.
  9. Pfizer And UCB Announce Formation Of New Company 'Cyclofluidic' To Accelerate Drug Discovery Process 10/20/2008
    Pfizer Ltd, and UCB today announced the formation of Cyclofluidic, a breakthrough technology company established with the aim of significantly accelerating the drug discovery process by allowing researchers to test a greater range of potential new medicines in a shorter time.
  10. Archemix Signs Aptamer Therapeutics Agreement With Lilly 10/20/2008
    Archemix Corp., a biotechnology company focused on discovering, developing and commercializing aptamer therapeutics, announced today that it has signed an agreement with Eli Lilly and Company (Lilly) regarding aptamer therapeutic R&D evaluation and access to intellectual property.